j&s studies

What j&s studies does

J&S Studies Inc. is an independently owned clinical research site founded in 1985 and headquartered at 1710 Crescent Pointe Parkway in College Station, Texas. The company conducts Phase I-IV clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs), with therapeutic area breadth spanning dermatology, allergy/immunology, infectious diseases, internal medicine, ENT, family medicine, gynecology, pain management, OTC product testing, provocative heartburn, and healthy volunteer studies, plus specialized pharmacokinetic studies and Phase I dermatology work. Since opening, J&S Studies has executed more than 400 clinical trials, leveraging proximity to Texas A&M University (48,000+ student enrollment) and a proprietary patient database to support enrollment velocity — a critical sponsor metric.

The company operates from a 4,300 square foot free-standing facility featuring eight examination rooms, semi-private in-house stay rooms, a CLIA-certified laboratory with refrigerated centrifuge and graduated (-80/-20/-15°C) freezer storage, 24/7 temperature monitoring, secure drug and record storage, and a private conference room for sponsor visits. Operational certifications include CLIA and dangerous goods shipping. The technical stack is clinical-operational rather than technology-platform in nature: central IRB capability, flexible operating hours including evenings and weekends, and certified specimen logistics. There is no disclosed digital health, AI, or platform technology component.

J&S Studies generates income via professional services fees for trial conduct, earned as project-based milestones under contract with pharma sponsors and CROs. The go-to-market model is direct enterprise engagement led by Clinical Director Jeremy Scott (BBA, CCRC, co-owner since 1995) and Medical Director Dr. Terry M. Jones, MD (20 years of clinical trial experience, published author, Medical Monitor). The company employs seven full-time clinical research coordinators with 2-34 years of tenure, a full-time receptionist, and part-time coordinators, phlebotomists, and clerical personnel. No funding rounds, institutional investors, parent company, or external capital have been disclosed; the company has operated independently since founding.

Name

j&s studies

Legal name

J&S Studies Inc.

Website

https://js-studies.com

Company type

Private

Founded year

1985

Operating status

Operating

Short description

J&S Studies is an independently owned clinical research site in College Station, Texas, founded in 1985, conducting Phase I-IV clinical trials for pharmaceutical sponsors and CROs across dermatology, allergy, infectious diseases, and 10+ additional therapeutic areas.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGAFAN

Nonclinical Study Management & Regulatory Writing (IND-enabling)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)

Keywords

• Clinical research services
• Clinical trial operations
• Pharmacokinetic studies
• Dermatology clinical trials
• Patient recruitment services

Headquarters

HQ city

College Station

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Trial Conduct Services: J&S Studies generates revenue by conducting clinical trials for pharmaceutical sponsors and Contract Research Organizations (CROs). Services include Phase I Dermatology studies, Phase II-IV trials across multiple therapeutic areas (Allergy/Immunology, Dermatology, ENT, Family Medicine, Gynecology, Infectious Diseases, Internal Medicine, OTC Product Testing, Provocative Heartburn, Pain Management), and Pharmacokinetic Studies. Revenue is project-based, earned as trials are conducted and milestones reached.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

J&S Studies operates an independent clinical research site in College Station, Texas, conducting pharmacokinetic studies, Phase I dermatology trials, and Phase II-IV trials for pharmaceutical sponsors and CROs. Its therapeutic scope includes allergy and immunology, dermatology, ENT, family medicine, gynecology, infectious diseases, internal medicine, over-the-counter product testing, provocative heartburn, pain management, and healthy-volunteer studies.

Product overview

J&S Studies Inc. is an independently owned clinical research organization established in 1985, offering a comprehensive suite of clinical trial services. The company operates from a 4,300 square foot free-standing research facility and provides Pharmacokinetic Studies, Phase I Dermatology trials, and Phase II-IV clinical trials across multiple therapeutic areas including Allergy/Immunology, Dermatology, ENT, Family Medicine, Gynecology, Infectious Diseases, Internal Medicine, OTC Product Testing, Provocative Heartburn, Pain Management, and Healthy Volunteer Studies. The company leverages its proximity to Texas A&M University for rapid patient enrollment and maintains a large patient database with central IRB capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmacokinetic Studies Clinical research studies for pharmaceutical sponsors and CROs that evaluate drug absorption, metabolism, and pharmacokinetic profiles.
• Phase I Dermatology Early-stage dermatology clinical trials for pharmaceutical sponsors and CROs that evaluate safety and dosing in human subjects.
• Phase II-IV Clinical Trials Mid- to late-stage clinical trials for pharmaceutical sponsors and CROs covering allergy and immunology, dermatology, ENT, family medicine, gynecology, infectious diseases, internal medicine, over-the-counter product testing, provocative heartburn, pain management, and healthy-volunteer studies.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves4 records

Expansion highlights1 record

Broad incumbents

• IQVIA: The largest global CRO with an extensive prime-site network and site management organization. Competes with J&S for sponsor trial allocations, though at vastly greater scale and with broader service breadth (full-service CRO plus site network).
• Velocity Clinical Research: A multi-site SMO network (formed by the combination of several independent research sites) conducting Phase II-IV trials across multiple therapeutic areas including dermatology. J&S is most directly comparable as a similarly-scoped clinical trial site business, though Velocity operates at materially greater scale.
• ICON plc: A global CRO with significant site operations (including the acquired MedaPhase and PRA Health Sciences site networks). Competes for dermatology and Phase I-IV trial placements where J&S also operates.
• Syneos Health: A global biopharmaceutical solutions provider combining CRO services with a clinical site network. Competes for sponsor dermatology and Phase II-IV trial placements; comparable as an incumbent with site-network infrastructure overlapping J&S's service offering.

Direct peers

• Accel Research Sites: A network of clinical research sites conducting Phase I-IV trials across dermatology, internal medicine, vaccines, and other therapeutic areas. Directly comparable as an SMO with multi-therapeutic site operations and a similar sponsor-facing business model.
• Benchmark Research: An independent clinical research site organization operating multiple locations with therapeutic breadth including dermatology, infectious disease, and internal medicine. Directly comparable as a multi-site independent SMO competing for similar Phase II-IV dermatology and internal medicine trials.
• Research Across America: An independent SMO operating multiple clinical research sites with experience in dermatology, internal medicine, and vaccine trials. Directly comparable as a competing independent site organization with similar sponsor relationships.
• Optimize Clinical Research: An independent SMO operating clinical trial sites across multiple U.S. locations with a therapeutic focus similar to J&S, including dermatology. Comparable as a competing independent site organization serving the same pharmaceutical sponsor base.

Emerging players

• Elligo Health Research: A technology-enabled clinical research site network bringing trials to community physicians. Comparable to J&S as an independent site-focused model, though with a tech-mediated decentralized trial approach versus J&S's traditional single-site model.
• Flourish Research: A growing multi-site clinical research organization focused on therapeutic areas overlapping with J&S (including dermatology and internal medicine). Comparable as a similarly-scaled independent SMO expanding site capacity.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about j&s studies